Alset Inc. - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AEI Nasdaq 2835 www.alsetinc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alset Inc.

Alset Inc. Announces Stock Repurchase Program - Jun 23rd, 2025 2:15 pm
Alset First Quarter 2025 Earnings: US$0.78 loss per share (vs US$0.73 loss in 1Q 2024) - May 17th, 2025 7:01 am
Alset Inc. Announces Engagement with the Robotics Sector - Mar 4th, 2025 7:20 am
One Alset Insider Raised Their Stake In The Previous Year - Feb 6th, 2025 7:18 am
Alset Inc. Announces Closing of $1.5 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules - Jan 3rd, 2025 12:08 pm
Alset Inc. Announces $1.5 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules - Jan 2nd, 2025 1:28 pm
Alset Third Quarter 2024 Earnings: EPS: US$0.19 (vs US$1.73 loss in 3Q 2023) - Nov 17th, 2024 5:08 am